These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6857093)

  • 21. Issues in therapeutic apheresis.
    Berkman E
    N Engl J Med; 1982 Jun; 306(23):1418-20. PubMed ID: 6804867
    [No Abstract]   [Full Text] [Related]  

  • 22. [Current status of the plasmapheresis problem].
    Kalinin NN
    Gematol Transfuziol; 1995; 40(2):46-8. PubMed ID: 7590069
    [No Abstract]   [Full Text] [Related]  

  • 23. Impact of factor VIII deficiency on clotting factor utilization in the United States.
    Aledort LM; Goodnight SH; Rao AV; Schwarz J; Whitehurst D; Shapiro SS
    Ric Clin Lab; 1983; 13(1):33-41. PubMed ID: 6407089
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Loss of red cell mass in a plasmapheresis machine: effect of rinsing the disposable tubing with normal saline and reinfusion.
    Fischer T; Surikova I; Heesen E; Wilms G; Laitinen T; Taborski U
    Transfus Apher Sci; 2013 Aug; 49(1):80-3. PubMed ID: 23769170
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PLASMAPHERESIS AS A FORM OF BLOOD DONATION.
    KLIMAN A; LESSES MF
    Transfusion; 1964; 4():469-72. PubMed ID: 14242763
    [No Abstract]   [Full Text] [Related]  

  • 26. Making blood money safe and respectable.
    White R
    FDA Consum; 1975 Dec-1976 Jan; 9(10):11-9. PubMed ID: 10305009
    [No Abstract]   [Full Text] [Related]  

  • 27. [Plasmapheresis for the isolation of coagulating plasma fractions].
    Matthes M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1970; 93(3):327-33. PubMed ID: 4195277
    [No Abstract]   [Full Text] [Related]  

  • 28. [Mechanical donor plasmapheresis using the Haemonetics Ultralite plasma collection system. 1. Collection of fresh plasma].
    Matthes G; Pawlow I; Richter E
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(2):343-8. PubMed ID: 2475417
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Decreased ionized calcium during therapeutic plasma exchange pheresis and platelet pheresis.
    Morse EE; Hohnadel DC; Genco P; Katz AJ
    Johns Hopkins Med J; 1980 Jun; 146(6):260-3. PubMed ID: 7382251
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Current problems in the development of plasmapheresis].
    Kochemasov VV; Rzhanovich AP; Maller AR; Iarustovskaia LE
    Gematol Transfuziol; 1984 Mar; 29(3):13-6. PubMed ID: 6714621
    [No Abstract]   [Full Text] [Related]  

  • 31. EFFECTS OF INTENSIVE PLASMAPHERESIS ON NORMAL BLOOD DONORS.
    KLIMAN A; CARBONE PP; GAYDOS LA; FREIREICH EJ
    Blood; 1964 May; 23():647-56. PubMed ID: 14142503
    [No Abstract]   [Full Text] [Related]  

  • 32. [A method of plasmapheresis in patients with hereditary hypercholesterolemia].
    Kulakov GP; Kukharchuk VV; Konovalov GA; Barsukov IuF; Semavin IE
    Ter Arkh; 1985; 57(7):107-8. PubMed ID: 4049259
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Neocytapheresis in donors].
    Kalinin NN; Varlamova SV; Pashinin AN; Petrov MM; Cherstvova LG; Ostrovskaia EE; Batashova TV
    Sov Med; 1991; (5):41-3. PubMed ID: 1876920
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Dynamic anti-Proteus immunity in plasma donors during plasmapheresis].
    Nazarchuk LV; Fedorovskaia EA
    Vrach Delo; 1991 May; (5):35-8. PubMed ID: 1866911
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Laboratory evaluation of normal donors undergoing leukapheresis on the continuous flow centrifuge.
    McCullough J; Fortuny IE
    Transfusion; 1973; 13(6):394-8. PubMed ID: 4584211
    [No Abstract]   [Full Text] [Related]  

  • 36. Volunteer blood donors for a cell pheresis programme.
    Woodfield DG; Ramirez A; Everard A; Kent J
    N Z Med J; 1985 Oct; 98(789):904-6. PubMed ID: 3864060
    [No Abstract]   [Full Text] [Related]  

  • 37. [Repercussions of the staggering increase of medical care costs in the Blood Transfusion Services].
    Hassig A
    Rev Fr Transfus Immunohematol; 1977 Dec; 20(4):559-63. PubMed ID: 601398
    [No Abstract]   [Full Text] [Related]  

  • 38. [Effectiveness of different methods of blood separation in performing plasma- and cytapheresis].
    Ryzhko VV; Gorodetskiĭ VM; Rogova EM
    Ter Arkh; 1988; 60(5):85-8. PubMed ID: 3175936
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Reactions observed in blood donors and patients during cytapheresis on the blood cell separator].
    Gorodetskiĭ VM
    Ter Arkh; 1978; 50(7):129-31. PubMed ID: 715711
    [No Abstract]   [Full Text] [Related]  

  • 40. Safeguards for plasma donors in plasmapheresis programs.
    JAMA; 1970 Aug; 213(5):743-7. PubMed ID: 5468413
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.